Neutropenia due to clopidogrel in a patient with end-stage renal disease [2]

Annals of Pharmacotherapy

Volumn 38, Issue 9, 2004, Pages 1538-1539

  Akcay, Ali ^a   Kanbay, Mehmet ^a   Agca, Erhan ^a   Sezer, Siren ^a   Ozdemk, Fatma Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM ACETATE; CLOPIDOGREL; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; MEROPENEM; SIMVASTATIN; VANCOMYCIN;

ADULT; ANEMIA; APLASTIC ANEMIA; ARTHRITIS; BONE MARROW BIOPSY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEBRILE NEUTROPENIA; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LETTER; MALE; NARANJO PROBABILITY SCALE; NEUTROPENIA; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 4143132020     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E119     Document Type: Letter

References (5)

1. CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
2. Trivier JM, Caron J, Mahieu M, Gambier N, Rose C. Fatal aplastic anaemia associated with clopidogrel (letter). Lancet 2001;357:446.
3. Bennett CL, Connors JM, Carwile JM, Moake JL, Bell WR, Tarantolo SR, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-7.
4. Andres E, Perrin AE, Alt M, Goichot B, Schlienger JL. Febrile pancytopenia associated with clopidogrel (letter). Arch Intern Med 2001;161:125.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.